Selina Wong
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 27, 2023
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy.Rebekah Rittberg, Bonnie Leung, Aria Shokoohi
|Nov 24, 2022
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.Lauren Jones, Rebekah Rittberg, Bonnie Leung
|Sep 06, 2022
End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non-Small-Cell Lung Cancer.Bonnie Leung, Selina K Wong, Cheryl Ho
|Dec 13, 2021
Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists.Selina K Wong, Lovedeep Gondara, Sharlene Gill
Pageof 1
